Evidence map›Paper›PMID 41512025›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

A chemogenetic approach for temporal and cell-specific activation of endogenous GPCRs in vivo.

Gwendolyn Shingles, Qianqian Pang, Jian Weng, Ryan Singer, Waleed Babar, Jiaqi Shen, Luis Vazquez-Rivera, Yao Chen, Peng Li, Wenjing Wang

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gwendolyn Shingles *Life Sciences Institute, University of Michigan, Ann Arbor, MI 48105.ORCID 0009-0002-3276-3224
Qianqian Pang *Life Sciences Institute, University of Michigan, Ann Arbor, MI 48105.
Jian Weng *Life Sciences Institute, University of Michigan, Ann Arbor, MI 48105.ORCID 0000-0001-9262-4993
Ryan SingerLife Sciences Institute, University of Michigan, Ann Arbor, MI 48105.ORCID 0009-0007-3146-2901
Waleed BabarDepartment of Neuroscience, Washington University in St. Louis, St. Louis, MO 63110.ORCID 0000-0003-1238-6978
Jiaqi ShenLife Sciences Institute, University of Michigan, Ann Arbor, MI 48105.
Luis Vazquez-RiveraLife Sciences Institute, University of Michigan, Ann Arbor, MI 48105.
Yao ChenDepartment of Neuroscience, Washington University in St. Louis, St. Louis, MO 63110.
Peng LiLife Sciences Institute, University of Michigan, Ann Arbor, MI 48105.ORCID 0000-0002-8992-0350
Wenjing WangLife Sciences Institute, University of Michigan, Ann Arbor, MI 48105.ORCID 0000-0001-6025-9848

Funding

Michigan Chemistry-Biology Interface Training ProgramT32GM132046 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Emily E Scott, Wenjing Wang · 2019 to 2026
$4.1M
Spatial, temporal, and context-dependent features of protein kinase A activityR01NS119821 · NINDS · WASHINGTON UNIVERSITY · PI Yao Chen · 2021 to 2026
$2.4M
New classes of optogenetic and chemogenetic tools with a feedback controlDP2MH132939 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, WENJING · 2022 to 2025
$2.3M
Dissecting neural circuits for breathing patternsR01AT011652 · NCCIH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LI, PENG · 2021 to 2025
$2.1M
Neural circuit control of sighingR01HL156989 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LI, PENG · 2022 to 2025
$1.5M
Development of innovative genetically encoded tools to dissect melanocortin-4 receptor signaling in neuronal circuitsF31DK145227 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ryan Elijah Singer · 2025 to 2026
$85k
Optimizing chemical- and light-dependent protein switches for controlling opioid peptide activity with temporal controlF31DA060678 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VAZQUEZ-RIVERA, LUIS ALONSO · 2025 to 2025
$24k
Alfred P. Sloan Foundation (APSF) FG-2024-22156Camille and Henry Dreyfus Foundation (CHDF) TC-23-084G. Harold and Leila Y. Mathers Foundation (Mathers Foundation) 28323HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL156989HHS | NIH | National Institute of Mental Health (NIMH) DP2MH132939HHS | NIH | National Institute of Mental Health (NIMH) R01AT011652NCCIH NIH HHS R01 AT011652NHLBI NIH HHS R01 HL156989NIDA NIH HHS F31 DA060678NIDDK NIH HHS F31 DK145227NIGMS NIH HHS T32 GM132046NIMH NIH HHS DP2 MH132939NINDS NIH HHS R01 NS119821
6 · The paper itself

Abstract

Cell-specific regulation of endogenous G protein-coupled receptors (GPCRs) is crucial for understanding their roles in physiological processes. We present chemogenetic tools using shield-1-dependent irreversible protein switches to regulate peptide agonist activity. To demonstrate this platform, we engineered chemogenetically regulated pituitary adenylate cyclase activating polypeptide (cPACAP), which exhibited >15-fold chemical-dependent regulation of endogenous receptor activity. In vivo application of cPACAP allowed neuronal activation via the endogenous receptor for PACAP, engaging neural circuits that control respiratory and feeding behaviors. By integrating cPACAP with transgenic mice, we selectively activated endogenous PACAP receptor signaling in hypocretin-expressing neurons of the lateral hypothalamic area (LHA), revealing its role in regulating sighing, a stress-related physiological output. We further extended this design to chemogenetically regulate the parathyroid hormone receptor and corticotropin-releasing factor peptide receptor activity. Using a common small molecule, these chemogenetic tools enable temporally regulated peptidergic activation of endogenous GPCRs in targeted cell populations, facilitating the study of their function.

Indexed as

Pituitary Adenylate Cyclase-Activating PolypeptideReceptors, G-Protein-CoupledReceptors, Pituitary Adenylate Cyclase-Activating PolypeptideAnimalsChemogeneticsHumansMiceMice, TransgenicNeuronsOrexinsSignal TransductionOrexinsPituitary Adenylate Cyclase-Activating PolypeptideReceptors, G-Protein-CoupledReceptors, Pituitary Adenylate Cyclase-Activating PolypeptidechemogeneticendogenousGPCR

Identifiers

PMID41512025
PMCPMC12799120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.